Related by context. Frequent words. (Click for all words.) 61 elotuzumab 60 prospectively defined 60 secondary efficacy endpoints 60 pharmacokinetic PK 60 Secondary endpoints 59 phase IIa 58 efficacy endpoint 57 subgroup analyzes 57 TAXUS Stent 57 univariate 57 metastatic castration resistant 57 NHANES III 57 Pivotal Trial 56 coronary revascularization 56 virologic response 56 Natural Catastrophe Stress 56 Pharmacokinetic 56 Clinical Trial Results 55 Phase III Clinical Trial 55 histopathological 55 multivariate analyzes 55 Myocardial Infarction 55 NLX P# 55 prespecified 55 Immunogenicity 55 biochemical recurrence 54 CCX# 54 HER2 positive metastatic breast 54 apolipoprotein B 54 Pivotal Phase 54 phase IIb 54 mRCC 54 Phase Ib clinical 54 renal dysfunction 54 covariate 54 Epratuzumab 54 Required fields 54 prospective observational 53 Pivotal Phase III 53 SABCS 53 QTc 53 Azedra 53 pharmacodynamic effects 53 Heart Failure Patients 53 Arch Neurol 53 dirucotide 53 relapsing multiple sclerosis 53 transurethral resection 53 phase IIb clinical 53 Solid Tumors 53 thromboembolic 53 heavily pretreated patients 53 Multicenter 53 systemic embolism 53 K RAS 53 placebo controlled clinical 52 histologic 52 Amrubicin 52 pulmonology portfolio 52 multicenter Phase 52 Phase III Trial 52 BestWeek subscribers 52 left ventricular dysfunction 52 AeroLEF TM 52 intravesical 52 Diabetic Macular Edema 52 neoadjuvant therapy 52 rHuPH# 52 fibrinolysis 52 Preclinical Data 52 ISTODAX 52 ischemic cardiomyopathy 52 Phase 1b trial 52 chlorambucil 52 Randomized controlled 52 platelet reactivity 51 calcineurin inhibitors 51 Phase Ib 51 acute coronary syndromes ACS 51 placebo controlled Phase 51 dose titration 51 Arch Intern Med 51 neurogenic orthostatic hypotension 51 stenoses 51 Panitumumab 51 prospective multicenter 51 Antihypertensive 51 Drug Candidate 51 Chronic Hepatitis C 51 tumor resection 51 randomized Phase III 51 www.jamamedia.org 51 androgen deprivation 51 Ischemic 51 registrational trial 51 chemoradiotherapy 51 imetelstat 51 TOLAMBA 51 stent implantation 51 multicenter randomized double 50 Main Outcome Measures